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The gut mucosa is continuously exposed to a vast community of microorganisms, 
collectively defined as microbiota, establishing a mutualistic relationship with the host 
and contributing to shape the immune system. Gut microbiota is acquired at birth, and 
its composition is relatively stable during the entire adult life. Intestinal dysbiosis, defined 
as a microbial imbalance of gut bacterial communities, can be caused by several fac-
tors, including bacterial infections and antibiotic use, and has been associated with an 
increased risk to develop or exacerbate immune-mediated pathologies, such as allergic 
reactions, asthma, and inflammatory bowel diseases. Still, the mechanisms by which 
antibiotic-induced gut dysbiosis may lead to development of mucosal inflammation are 
still matter of debate. To this end, we aimed to evaluate the impact of antibiotic treatment 
on phenotype and functions of intestinal immune cell populations, including invariant 
natural killer T (iNKT) cells, a subset of lipid-specific T  cells profoundly influenced by 
alterations on the commensal microbiota. To this aim, a cocktail of broad-spectrum 
antibiotics was administered for 2 weeks to otherwise healthy mice before re-coloni-
zation of the intestinal microbial community with oral gavage of eubiotic or dysbiotic 
mucosa-associated bacteria and luminal colonic content, followed or not by intestinal 
inflammation induction. Here. we showed that short-term antibiotic treatment alters 
frequency and functions of intestinal iNKT cells, even in the absence of intestinal inflam-
mation. The presence of a dysbiotic microbiota after antibiotic treatment imprints colonic 
iNKT and CD4+ T cells toward a pro-inflammatory phenotype that collectively contributes 
to aggravate intestinal inflammation. Nonetheless, the inflammatory potential of the 
dysbiotic microbiota decreases over time opening the possibility to temporally intervene 
on the microbial composition to re-equilibrate dysbiosis, thus controlling concomitantly 
mucosal immune T cell activations.
Keywords: inKT cells, antibiotics, microbiota, T cells, intestinal inflammation
Abbreviations: iNKT, invariant natural killer T cells; GF, germ free; ABX, antibiotics; Th, T helper; IBD, inflammatory bowel 
diseases; FMT, fecal microbiota transplantation.
2Burrello et al. Antibiotics Affect Colonic T lymphocytes
Frontiers in Medicine | www.frontiersin.org February 2018 | Volume 5 | Article 21
inTrODUcTiOn
The gut mucosa is a complex environment, constantly exposed to a 
vast community of microorganisms, collectively defined as micro-
biota, which include bacteria, fungi, protozoa, and viruses (1). 
Intestinal microbiota establishes a mutualistic relationship with 
the host, providing metabolic functions and contributing to shape 
the immune system (2). Indeed, germ-free mice (GF) manifest 
profound defects in the immune system development and function 
(3). Moreover, the presence of specific bacterial strains in the gut, 
such as segmented filamentous bacteria and Clostridia cluster IV 
and XIV, have been linked, respectively, to the differentiation and 
expansion of IL-17 producing CD4+Th17 cells (4) and of Foxp3+ 
regulatory T cells (5). To preserve intestinal immune homeostasis, 
active processes must thus operate, aimed at preserving the capac-
ity of the gut-associated immune system to recognize invading 
pathogens and simultaneously avoiding immune responses against 
the commensal intestinal microbiota (1).
Intestinal dysbiosis, defined as a perturbation to the structure 
of intestinal commensal communities (6), can be triggered by 
several factors, including a persistent change in dietary habits, 
gastrointestinal infections, and alcohol misuse (7). Antibiotic 
administration can also lead to a profound perturbation of 
intestinal commensal communities, which persists after cessation 
of therapy, as a consequence of their broad-spectrum of action 
(8, 9). Clinical evidences support a correlation between antibi-
otic use and emergence or exacerbation of immune-mediated 
inflammation, as shown for atopic reactions (10), asthma (11), 
and inflammatory bowel diseases (IBD) (12). Importantly, several 
studies have consistently demonstrated that antibiotic use early in 
life predisposes to IBD emergence in Western populations (13).
Despite these evidences, the impact of antibiotic treatment and 
antibiotic-induced dysbiosis on distinct immune cells functions 
is still largely unexplored. In this context, few recent data indicate 
that neonatal mice treated with vancomycin or colistin manifest 
reduced intestinal lymphoid follicles, while broad-spectrum 
antibiotics administration diminishes antimicrobial peptides 
production (14). Vancomycin treatment additionally decreases 
Tregs colonic frequencies (15) while prolonged broad-spectrum 
antibiotics exposure induces intestinal and systemic alterations 
in the immune repertoire, including memory/effector T  cells, 
Tregs, and dendritic cells (16). At present, however, it is unknown 
the effect of antibiotic treatment on frequency and functions of 
intestinal lipid-specific T cells such as iNKT cells.
Invariant natural killer T cells are a subset of CD1d-restricted 
αβ-T lymphocytes recognizing both self- and microbial-derived 
glycolipids (17–19) and showing both innate and adaptive 
immune characteristics (20). In line with data from conventional 
CD4+ T cells (4, 5, 15), increasing evidences support the exist-
ence of mutual mechanisms of regulation between the intestinal 
microbiota and iNKT  cells (21). During early neonatal and 
postnatal stages of development, commensal bacteria negatively 
shape iNKT cell repertoire through a CXCL16-dependent gradi-
ent (22). Additionally, CD1d-dependent lipid antigens isolated 
from the commensal B. fragilis directly influence iNKT  cell 
proliferation and activation status (23).
Here we evaluated the effect of antibiotics and antibiotic-
induced microbiota alterations on colonic T  cell immune 
responses, focusing specifically on iNKT  cells. We tested the 
consequences of re-colonization of the gastrointestinal tract with 
normal or dysbiotic microbiota on iNKT  cell phenotype and 
function and how it might translate into a specific outcome in 
the absence or presence of intestinal inflammation.
We provide evidences that antibiotic treatment in adult mice 
profoundly alters frequency and functions of intestinal iNKT cells 
even in the absence of intestinal inflammation, and that the 
presence of a dysbiotic microbiota after antibiotic treatment 
imprints colonic iNKT and conventional CD4+ T  cells toward 
a pro-inflammatory phenotype that altogether contributes to 
aggravate intestinal inflammation. Nonetheless, the inflamma-
tory potential of the dysbiotic microbiota decreases over time, 
opening the possibility to temporally intervene to re-equilibrate 
dysbiosis, thus controlling concomitantly mucosal immune cell 
activations.
MaTerials anD MeThODs
Mice
C57BL/6 mice (Charles River, IT) and CXCR6-EGFP/+ mice (pur-
chased as GFP/GFP from JAX, USA, and bred to heterozigosity 
with C57BL/6 mice) of 8–10  weeks of age were housed at the 
IEO animal facility in SPF conditions. Animal procedures were 
approved by the Italian Ministry of Health (Auth. 127/15, 27/13, 
913/16).
experimental colitis Models
For the induction of acute colitis, mice were given 2% (w/v) DSS 
(molecular weight 40 kD; TdB Consultancy) in their drinking 
water for 7 days followed by 2 days of recovery before sacrifice. 
The weight curve was determined by weighing mice daily. At 
sacrifice, colons were collected, their length was measured 
with a caliper, and then divided in portions to be fixed in 
10% formalin for histological analyses, snap-frozen for RNA 
extraction, and for lamina propria mononuclear cells (LPMC) 
immunophenotyping.
antibiotic Treatment and Microbiome 
reconstitution
To eliminate the gut microflora, mice were administered with a 
mix of neomycin (1 g/L), ampicillin (1 g/L), vancomycin (0.5 g/L), 
and metronidazole (1 g/L) in their drinking water. After 14 days 
of antibiotic treatment, mice received a transfer of mucus (first 
day) and feces (second and third days) from untreated (eubiotic) 
or DSS-treated (dysbiotic) donors by oral gavage. Mucus was 
scraped from donor colons, diluted in PBS, and administered to 
recipients at 1:1 ratio. Feces were collected from different donor 
mice, diluted in PBS (50 mg/mL), and administered to recipients 
by oral gavage. Mice were sacrificed at different time points 
according to the experimental settings. In some experiments after 
fecal microbiota transplantation (FMT), acute colitis was induced 
by administration of 2% DSS.
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cell isolation
For the isolation of LPMC from colons, Peyer’s patches were 
removed, lamina propria lymphocytes were isolated via incuba-
tion with 5 mM EDTA at 37°C for 30 min, followed by further 
digestion with collagenase IV and DNase at 37°C for 1 h. Cells 
were then separated with a Percoll density gradient (Sigma-
Aldrich, St. Louis, MO, USA). Mesenteric LN and spleens were 
smashed into 70-µm nylon strainers (BD) and eritrocytes lysed 
with RBC Lysis buffer (BD). Livers were mechanically dissected 
and mononuclear cells separated with a Percoll density gradient 
(Sigma-Aldrich, St. Louis, MO, USA).
In some experiments, after isolation, cells were re-stimulated 
in vitro for 3 h with PMA/ionomycin in the presence of Brefeldin 
A to evaluate cytokine secretion.
Flow cytometry analysis
Mouse iNKT cells were identified by CXCR6-EGFP expression or by 
mCD1d:PBS57 Tetramer (NIH Tetramer core facility) staining. 
Murine cells were stained with combinations of directly conju-
gated antibodies: CD45.2 (104), CD3 (17A2) CD8α (53–6.7), 
CD4 (GK1.5), CD69 (H1.2F3), CD19 (1D3), CD11b (M1/70), 
F4/80 (BM8), Ly6g (1A8), Ly6c (AL-21), CD11c (HL3) all pur-
chased from BD, eBioscience, or Biolegend. Gating strategy to 
identify T cells comprised the exclusion of CD11b+, CD19+, and 
CD11c+ cells (defined as “lineage”).
Intracellular staining of cytokines was performed accord-
ing to standard methods. Cells were fixed and permeabilized 
with Cytofix/Cytoperm (BD) before addition of the following 
antibodies: anti-IFNg (XMG1.2), anti-IL17A (TC11-18H10.1), 
anti-IL10 (JES5-16E3), anti IL22 (Poly5164) (BD or eBioscience 
or Biolegend). Samples were analyzed by a FACSCanto flow 
cytometer (BD), gated to exclude nonviable cells. Data were 
analyzed using FlowJo software (Tristar).
qPcr Protocol for Quantification of Tissue 
mrna
Total RNA from mouse colonic tissues was isolated using TRIZOL 
and Quick-RNA MiniPrep (ZymoResearch) according to manu-
facturer’s instructions. cDNAs were generated from 1 µg of total 
RNA with reverse transcription kit (Promega). Gene expression 
levels were evaluated by qPCR and normalized to Rpl32 gene 
expression. The primer sequences are collected in Table S1 in 
Supplementary Material.
16s qPcr Protocol for Quantification of 
Bacterial Dna
Total bacterial DNA was extracted from mouse feces with the 
G’NOME DNA extraction kit (MP Biomedicals) according to 
manufacturer’s specifications. Bacterial DNA was analyzed by 
qPCR using 16S rDNA primers (SIGMA) and collected in the 
Table S1 in Supplementary Material. The relative abundance of 
each bacterial group was normalized to Eubacteria using the 
2−ΔΔCt method.
histological analysis
Tissue processing was performed with a LEICA PELORIS 
processor before paraffin embedding. Murine samples were 
included using an automated system (SAKURA Tissue-Tek). 
After Hematoxylin and Eosin staining, snapshots of histology 
were taken using an Aperio CS2 microscope with a scanning 
resolution of 50,000 pixels per inch (0.5 µm per pixel with 10× 
objective and 2.5 µm per pixel when scanning at 4×). Scoring of 
disease activity was performed according to the criteria described 
in Table S2 in Supplementary Material.
statistical analysis
Statistical significance was calculated using Kruskal–Wallis 
nonparametric test for multiple comparisons or unpaired non-
parametric Mann–Whitney t-test for comparisons between two 
groups. P < 0.05 (*), P < 0.01 (**) P < 0.001 (***) were regarded 
as statistically significant. Outliers detected with Grubb’s test.
resUlTs
antibiotic Treatment influences colonic 
inKT cell Frequency and Phenotype
To assess the effects of antibiotic treatment on intestinal 
iNKT  cells phenotype and function under homeostatic condi-
tions, CXCR6-EGFP/+ mice were treated for 2 weeks with a broad-
spectrum antibiotic cocktail (ABX, vancomycin, metronidazole, 
ampicillin, penicillin), targeting both aerobic and anaerobic 
bacteria (Figure  1A). CXCR6-EGFP/+ mice are a useful strain to 
track iNKT cells (24). The complete depletion of intestinal micro-
biota by ABX treatment was confirmed by colony forming unit 
analysis and qPCR analyses (data not shown). Subsequently, mice 
were either maintained in ABX treatment (ABX, upper scheme) 
or reconstituted by oral gavage with mucosa-associated and fecal 
bacteria (FMT; Figure 1A, middle scheme). To evaluate whether 
the characteristics of the microbiota utilized to reconstitute the 
gastrointestinal tract upon ABX treatment might have a sub-
sequent impact on iNKT  cells frequency and function, mucus 
and feces derived from healthy mice (eubiotic FMT) or from 
mice with intestinal dysbiosis (dysbiotic FMT) were engrafted 
to ABX-treated mice (Figure  1A, middle scheme). Dysbiotic 
microbiota was obtained from mice with acute DSS colitis, as we 
and others have observed that this condition is associated with a 
relevant alteration of both fecal and mucosa-associated micro-
bial composition (25) (Figure  1B). Histological evaluation of 
colonic tissues (Figure 1C) and qPCR analyses of tissue derived 
mRNA (Figure  1D) revealed that neither antibiotic treatment 
nor recolonization with eubiotic or dysbiotic microorganisms 
induced macroscopic changes in the colonic tissue architecture 
(Figure 1C) and all treatments failed to upregulate inflammatory 
genes (Figure 1D).
In sharp contrast, treatment of adult mice with broad spec-
trum antibiotics was sufficient to induce a significant expansion 
of iNKT cells in the colon (Figures 2A–C; Figures S1 and S2 in 
Supplementary Material). Importantly, reconstitution of the gut 
microbiota with a eubiotic FMT restored iNKT  cell frequency 
(Figures  2A–C), a phenomenon that was not observed upon 
microbial reconstitution with the microbiota derived from DSS-
treated mice. In contrast with these data, CD4+ T cells accumula-
tion in the colon was unaffected by antibiotic treatment or by 
microbiota recolonization, regardless its origin (Figures 2A–C).
FigUre 1 | Antibiotic treatment does not alter mucosal architecture under homeostatic conditions. (a) Schematic representation of the treatments. (B) Abundances 
of dominant mucus-associated and fecal bacterial groups (phyla level on the left and class level among Firmicutes on the right) derived from untreated and 
DSS-treated mice and utilized to recolonize ABX-treated mice (c) H&E staining and cumulative histological score on colon specimens of untreated (open circles), 
antibiotic treated (ABX, closed circles), transplanted with eubiotic (open squares) or dysbiotic fecal microbiota transplantation (FMT) (closed squares), and of 
DSS-treated mice (closed diamonds). Scale bar 100 μm. (D) Colonic expression levels of Il6, il17a, tnf, mcp-1, il-12 in untreated (white bars), ABX-treated (gray 
bars), reconstituted with eubiotic (striped bars) or dysbiotic (dotted bars) FMT or in DSS-treated mice (black bars). Significance was determined using Kruskal–Wallis 
nonparametric test and expressed as mean SEM untreated n = 8, ABX-treated n = 10, reconstituted with eubiotic FMT n = 9, with dysbiotic FMT n = 11, or in DSS-
treated n = 11 mice in four independent experiments. Outliers detected with Grubb’s test. P < 0.05 (*), P < 0.001 (***) were regarded as statistically significant.
4
Burrello et al. Antibiotics Affect Colonic T lymphocytes
Frontiers in Medicine | www.frontiersin.org February 2018 | Volume 5 | Article 21
The expression of CD69 (Figure 2D), a surface molecule asso-
ciated to T cells functional activation, and the cytokine profile 
(Figure 2E) of both iNKT cells and CD4+ T cells isolated from 
ABX-treated mice did not significantly differ from that of cells 
isolated from mice reconstituted with an eubiotic microflora. 
Conversely, re-colonization of ABX-treated mice with a dysbiotic 
microbiota was sufficient to upregulate CD69 and to stimulate 
IFNg secretion by both iNKT cells (Figures 2D,E), and by CD4+ 
colonic T cells.
Interestingly, these effects were observed in iNKT cells isolated 
from the colon, but not from the mesenteric LNs (mLN) or from 
the spleens (Figure S3 in Supplementary Material) of treated mice, 
thus confirming that the tight regulation of iNKT cells frequency 
and functions operated by the commensal microbiota occurs in 
the colonic microenvironment rather than in the periphery (23).
Taken together, these results suggest that expansion of colonic 
iNKT cells and CD4+ T cells are differentially modulated upon 
antibiotic treatment in the absence of intestinal inflammation, 
and that the microbiota composition influences both the accu-
mulation and the functional activation of colonic iNKT cells.
recolonization of antibiotic-Treated Mice 
with a Dysbiotic Microbiota aggravates 
subsequent intestinal inflammation
Since the nature of the microbiota utilized to reconstitute the gas-
trointestinal tract following antibiotic treatment exerted an influ-
ence over expansion and cytokine profile of colonic iNKT cells, 
we next assessed whether these effects translated into a parallel 
effect over experimental intestinal inflammation. To address this 
FigUre 2 | Antibiotic treatment influences colonic invariant natural killer T (iNKT) cell frequency and function (a–c) representative dot plots (a), cumulative 
frequency (B), and absolute numbers (c) of iNKT cells (upper panels) and CD4+ T cells (lower panels) in untreated mice (open circles), ABX-treated mice (closed 
circles), mice reconstituted with eubiotic fecal microbiota transplantation (FMT) (open squares), or with microbiota from DSS-treated mice (dysbiotic FMT, closed 
squares). (D) Absolute numbers of CD69+ cells among iNKT cells (upper panels) and CD4+ T cells (lower panels) in untreated mice (white bars), ABX-treated mice 
(light gray bars), mice reconstituted with eubiotic FMT (dark gray bars), or with microbiota from DSS-treated mice (dysbiotic FMT, black bars) (e) Cytokine production 
by iNKT cells (upper panels) and CD4+ T cells (lower panels) in untreated, ABX-treated, reconstituted with eubiotic or with dysbiotic FMT. Histograms normalized to 
100% of production of total cytokines. Significance was determined using Kruskal–Wallis nonparametric test and expressed as mean SEM. Untreated n = 8, 
ABX-treated n = 10, reconstituted with eubiotic FMT n = 9, with dysbiotic FMT n = 11 or in DSS-treated n = 11 mice in four independent experiments. Outliers 
detected with Grubb’s test. P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) were regarded as statistically significant.
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issue, mice were treated with broad-spectrum ABX for 2 weeks 
before reconstitution with either eubiotic or dysbiotic micro-
biota. Shortly after re-colonization, acute colitis was induced by 
administration of DSS in their drinking water (Figure 3A). Of 
note, mice recolonized with a dysbiotic microbiota exhibited a 
more severe colitis (as indicated by a more profound weight loss, 
Figure 3B, and a higher histological score, Figure 3D) than those 
reconstituted with a eubiotic microbiota. No difference was found 
in colon length (Figure  3C). Reconstitution with a dysbiotic 
microflora was sufficient to upregulate colonic ifng (Figure 3E).
Taken together, these results suggest that presence of an 
underlying dysbiotic microbiota may exert a negative influence 
over subsequent experimental intestinal inflammation.
inKT cells exposed to a Dysbiotic 
Microbiota acquire an activated and 
Pro-inflammatory Phenotype
We next evaluated if the observed negative effects of the re-col-
onization with a dysbiotic microbiota after antibiotic treatment 
were associated to a specific phenotype of colonic iNKT  cells. 
First, the colonic expression levels of cxcl16, the chemokine 
responsible for iNKT cells tissue attraction (22), were evaluated 
(Figure  4A). Colonic cxcl16 levels were strongly upregulated 
by DSS treatments, as compared to its level after reconstitution 
with eubiotic FMT in the absence of inflammation (Figure 4A). 
Noteworthy, reconstitution of ABX-treated mice with dysbiotic 
microbiota-induced cxcl16 expression at similar levels as those of 
DSS without prior ABX treatement. Consistently, a marked accu-
mulation of iNKT cells, and also of CD4+ T cells, was observed in 
the colon of mice upon DSS administration (Figure 4B).
As a consequence of higher cxcl16 expression and increased 
chemoattraction, colonic iNKT cells were more abundant in mice 
reconstituted with a dysbiotic microbiota than those reconstituted 
with a eubiotic microbiota (Figure 4B).
Additionally, a tendency of a higher accumulation of colonic 
iNKT  cells expressing CD69 was observed in colitic mice 
re-colonized with a dysbiotic microbiota after ABX treatment 
(Figure 4C). Similarly to CD69 expression, the cytokine profile 
of colonic iNKT cells isolated from colitic mice re-colonized with 
dysbiotic microbiota was skewed toward a pro-inflammatory 
Th1/Th17 cytokine profile (Figure 4D), which in CD4+ T cells 
is associated to pathogenic properties (26). On the contrary, 
re-colonization of the gastrointestinal tract with a eubiotic micro-
biota did not sustain the activated/inflammatory phenotype of 
iNKT cells, but rather maintained them toward an uninflamed/
IL10-secreting cytokine profile (Figure 4D).
As for colonic CD4+ T  cells, no differences were observed 
among DSS-treated groups in terms of CD69 expression 
(Figure 4E), although also CD4+ T cells isolated from mice re-
colonized with dysbiotic microbiota before colitis induction were 
similarly skewed toward a Th1/Th17 cytokine profile (Figure 4F).
Taken together, these data indicate that re-colonization of the 
gastrointestinal tract after antibiotic treatment with a dysbiotic 
microbiota, but not with an eubiotic microbiota, sustains the 
accumulation of iNKT cells (and of CD4+ T cells) with an acti-
vated and pro-inflammatory/colitogenic phenotype.
Dysbiotic Microbiota effects after 
antibiotic Treatment on colonic inKT cells 
are Time-Dependent
We next aimed to evaluate whether the negative effects of re-
colonization with dysbiotic microbiota over intestinal inflam-
mation were persistent over time (Figure  5A). To this end, 
mice were treated with ABX for 2 weeks and then reconstituted 
FigUre 3 | Reconstitution of ABX-treated mice with dysbiotic microbiota aggravates subsequent intestinal inflammation. (a) Schematic representation of the 
treatment. (B) Weight loss, (c) colon length, and (D) histological evaluation of mice treated with eubiotic FMT before water administration or treated with normal or 
dysbiotic fecal microbiota transplantation (FMT) before DSS administration, or treated with DSS without prior exposure to antibiotics. *Statistical analysis between 
normal FMT + H20 and DSS; §Statistical analysis between eubiotic FMT + H20 and dysbiotic FMT + DSS performed with Mann–Whitney test. (D) Shows H&E 
staining on colon specimens. Scale bar 100 μm. (e) Colonic expression levels of ifng in mice reconstituted with eubiotic microbiota and unchallenged (gray bars), 
reconstituted with eubiotic bacteria and DSS-treated (striped bars), reconstituted with dysbiotic microbiota and DSS-treated (dotted bars) and DSS-treated (black 
bars). Eubiotic FMT + H20 n = 6, eubiotic FMT + DSS n = 4, dysbiotic FMT + DSS n = 4, or DSS-treated n = 5 mice, two independent experiments. Significance 
was determined using Kruskal–Wallis nonparametric test and expressed as mean SEM Outliers detected with Grubb’s test. P < 0.05 (* and §), P < 0.01 (** and §), 
P < 0.001 (***) were regarded as statistically significant.
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with either a eubiotic or a dysbiotic microbiota. This time, DSS 
administration was performed 1 week after the last microbiota 
gavage (Figure  5A). By following this protocol, no differences 
could be observed between the effects of eubiotic and dysbiotic 
re-colonization after antibiotic treatment in terms of weight loss 
(Figure  5B), colon length reduction (Figure  5C), histological 
score (Figure 5D), and expression of inflammatory genes in the 
colonic tissue (Figure 5E).
Similarly, the difference in colonic cxcl16 expression between 
mice re-colonized with eubiotic or dysbiotic microbiota was 
abolished when a longer time was allowed before colitis induction 
(Figure 6A), mirrored by similar recruitment and abundance of 
colonic iNKT cells among the two groups (Figure 6B). A similar 
re-equilibration between the effects of eubiotic and dysbiotic 
reconstitution before colitis induction was observed also on the 
activation status (Figure 6C) and cytokine profile (Figure 6D) 
of iNKT  cells. To note, the differences of pro-inflammatory 
phenotype induction on conventional CD4+ T  cells between 
eubiotic and dysbiotic microbiota exposure were also abolished 
(Figures 6E,F).
Taken together, these results confirm that the pro-inflamma-
tory effects of the dysbiotic microbiota over colitis development 
might be significantly affected by the time allowed for microbial 
reconstitution.
DiscUssiOn
The immune system and the host microbiota shape each other 
throughout life, generating an equilibrium that is daily challenged 
as a result of exposure to pathogens, to environmental factors, 
or to dietary changes (1). Recently, antibiotic usage has been 
identified as one important trigger of disequilibrium between 
the immune system and the intestinal microbiota (8), with 
still poorly understood consequences on the overall human 
health.
We here report that a short-term broad-spectrum antibiotic 
administration is sufficient to affect the phenotype and function 
of colonic iNKT cells and that the re-colonization of the intestinal 
microbiota with dysbiotic, but not with eubiotic, microorganisms 
aggravates subsequent intestinal inflammation by sustaining 
T cells pro-inflammatory phenotype.
A healthy microbial ecosystem is defined by its richness and 
its resistance to external perturbations. Data from the Human 
Microbiome Project (27) indicate that multiple eubiotic states 
FigUre 4 | T cell responses are affected by the origin of the transplanted microbiota. (a) Colonic expression levels of cxcl16 in mice reconstituted with eubiotic 
bacteria and unchallenged (white bars), reconstituted with eubiotic bacteria and DSS-treated (light gray bars), reconstituted with dysbiotic bacteria and DSS-treated 
(dark gray bars) and DSS-treated (black bars). (B) Absolute numbers of colonic invariant natural killer T (iNKT) cells (white bars) and CD4+ T cells (black bars) in the 
indicated experimental groups. (c,e) CD69 absolute numbers of colonic iNKT cells (c) and of colonic CD4+ T cells (e). (D,F) Cytokine production by iNKT cells (D) 
and of CD4+ T cells (F) in the indicated experimental groups. Histograms normalized to 100% of production of total cytokines. Significance was determined by 
Kruskal–Wallis nonparametric test. Eubiotic fecal microbiota transplantation (FMT) + H20 n = 6, eubiotic FMT + DSS n = 4, dysbiotic FMT + DSS n = 4, or 
DSS-treated n = 5 mice, two independent experiments. Outliers detected with Grubb’s test. P < 0.05 (*), P < 0.01 (**) were regarded as statistically significant.
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of the microbial ecosystem, whose taxonomic compositions 
are influenced by geography, age, and dietary habits, co-exist 
throughout life even without manifest signs of disease (7). 
Dysbiosis can be defined as any short-term or stable alteration in 
the microbial ecology affecting the taxonomical composition as 
well as the metagenomic functions of the microbial community 
FigUre 5 | Dysbiotic fecal microbiota transplantation (FMT) effects are time-dependent (a) Schematic representation of treatment. (B) Weight loss, (c) colon 
length, and (D) histological evaluation of mice treated with ABX before DSS administration or treated with eubiotic or dysbiotic FMT before DSS administration or 
with DSS. (D) Shows H&E staining on colon specimens. Scale bar 100 μm. (e) Colonic expression levels of tnf, cxl10, and il6 in ABX-treated mice before DSS 
treatment (gray bars), reconstituted with eubiotic bacteria and DSS-treated (striped bars), reconstituted with dysbiotic bacteria and DSS-treated (dotted bars) and 
DSS-treated (black bars). Significance determined using Kruskal–Wallis nonparametric test and expressed as mean SEM P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) 
were regarded as statistically significant.
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(7). Growing evidences support the notion that antibiotic 
exposure cause short-term and long-term intestinal dysbiosis by 
reducing or completely removing normally residing members of 
the microbiota, as a consequence of microbial killing or dimin-
ished bacterial proliferation (8, 28, 29).
Even though it has been extensively shown that microbiota 
absence in GF mice impacts the immune system development 
and function (3, 30), the effects of antibiotic-dependent micro-
biota ablation on the mucosal immune system has so far been 
poorly studied. Antibiotic exposure in early life reduces bacterial 
diversity and alters the composition of the commensal microbiota 
(8), a phenomenon linked to increased susceptibility to develop 
immune-related pathologies in adult life such as allergic inflam-
mation and asthma (10, 11).
A recent report indicate that prolonged (8  weeks) broad 
spectrum ABX usage (16) induces a reduction in the relative 
abundance of several immune cell populations, including T cells, 
both in periphery and in the intestinal tissues. This event can 
be reverted by re-colonization of antibiotic-treated mice with a 
normal microflora.
Here, we show that also a shorter exposure to a broad-spectrum 
ABX cocktail, a schedule of treatment closer to the ones used in 
clinical practice is sufficient to induce alterations in the relative 
abundances and cytokine profile of lipid-specific iNKT  cells 
FigUre 6 | Dysbiotic microbiota effects after antibiotic treatment on colonic invariant natural killer T (iNKT) cells are time-dependent. (a) Colonic expression levels of 
cxcl16 in mice treated with antibiotics and treated with DSS (white bars), transplanted with eubiotic bacteria and DSS-treated (light gray bars), transplanted with 
dysbiotic bacteria, and DSS-treated (dark gray bars) and DSS-treated (black bars). (B) Absolute numbers of colonic iNKT cells (white bars) and CD4+ T cells (black 
bars) in the indicated experimental groups. (c,e) CD69 absolute numbers of colonic iNKT cells (c) and of colonic CD4+ T cells (e). (D,F) Cytokine production by 
iNKT cells (D) and CD4+ T cells (F) in the indicated experimental groups. Histograms normalized to 100% of production of total cytokines. Significance determined 
using Kruskal–Wallis nonparametric test and expressed as mean SEM. ABX + DSS n = 5, eubiotic FMT + DSS n = 6, dysbiotic FMT + DSS n = 7, DSS-treated 
n = 6 mice, two independent experiments. Outliers detected with Grubb’s test. P < 0.05 (*) were regarded as statistically significant.
9
Burrello et al. Antibiotics Affect Colonic T lymphocytes
Frontiers in Medicine | www.frontiersin.org February 2018 | Volume 5 | Article 21
and of conventional CD4+ T  cells. Interestingly, 2  weeks ABX 
administration does not induce macroscopic signs of inflamma-
tion, as demonstrated by unaltered colonic architecture and low 
expression of inflammatory genes by the colonic mucosa, but it is 
sufficient to expand colonic iNKT cells and imprint them toward 
an inflammatory profile.
We observed that upon antibiotic treatment, only colonic 
iNKT cells, but not those residing in the mLN or in the spleen, 
increased in frequency. Alterations in the survival of colonic 
iNKT  cells or the incremented availability of colonic CXCL16 
might be associated to iNKT  cells frequency increase upon 
antibiotic treatment. In addition, this observation can be 
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explained by the notion that iNKT cell proliferative capacity is 
negatively regulated by the presence in the intestinal microflora 
of the commensal microbe B. fragilis (22). In GF mice, where 
B. fragilis is absent, mucosal iNKT cells expand without control 
(22). Similarly, broad-spectrum antibiotics induce a rapid and 
significant drop in taxonomic richness and diversity, including 
a reduction in Bacteroidetes (28, 29), thus suggesting a similar 
explanation for the observed iNKT  cell frequency increase 
in ABX-treated mice. Re-colonization of the gastrointestinal 
tract with a Bacteroidetes-rich healthy microbiota explains the 
observed iNKT  cells frequency normalization upon eubiotic 
bacterial reconstitution.
Colonic conventional CD4+ T cells are also influenced by the 
presence or absence of specific bacterial strains (4, 5). GF mice 
manifest impairments in CD4+ T  cell functions (1, 30) while 
Vancomycin administration, selectively ablating Gram-negative 
bacteria, causes reduction of Tregs in colonic LP (5, 31). In our 
model, we did not observe variations in the frequency of CD4+ T 
helper (Th) cells, neither in the colon nor in the mesenteric LN 
or spleen, after 2 weeks broad-spectrum antibiotic administra-
tion. On the contrary, it was previously shown that a longer ABX 
treatment (8 weeks) could affect CD4+ and CD8+ T cells intestinal 
frequencies (16), suggesting that a shorter antibiotic exposure 
may not be sufficient to induce changes in the expansion of the 
MHC-restricted T cell population, as instead observed for non-
classical lipid-specific iNKT cells.
We also observed that ABX treatment induced a skewing 
toward a pro-inflammatory cytokine profile in both colonic 
iNKT cells and conventional CD4+ T cells. No data were avail-
able so far on cytokine profile skewing upon short-term antibiotic 
treatment in colonic T cells. It was reported that a cocktail of ABX 
for 2 weeks was capable to skew the cytokine profile of systemic 
T  cells promoting Th2 responses (32), similarly to short-term 
Kanamycin administration in 3-week-old mice (33). A longer 
antibiotic treatment, instead, completely abrogated the overall 
cytokine production by intestinal CD4+ T cells (16), supporting 
the hypothesis that the duration of antibiotic treatment might 
differentially impact on the cytokine producing capability of 
intestinal T cells.
It has also been shown that re-association of antibiotic-treated 
mice with distinct bacterial species could alter the cytokine 
profile of conventional T  cells (33). Enterococcus faecalis and 
Lactobacillus acidophilus could revert or attenuate the cytokine 
skewing of conventional Th subsets, while Bacteroides vulgatus 
caused exacerbation of Th-2 inflammatory responses (33).
Intestinal inflammation induces profound alterations of the 
gut microbiota ecosystem (34). IBD patients harbor an important 
bacterial diversity as compared to not-IBD controls, defined by an 
increase in Proteobacteria (such as E. coli adherent invasive and 
Enterobacteriaceae in CD) and a decrease in Firmicutes (such 
as F. prausnizii) (35). Also, DSS-treated mice harbor a dysbiotic 
microbiota enriched in pathobionts (25), namely commensal 
microorganisms that bear the potential to cause pathology. These 
types of microorganisms are enriched in human IBD (36) and 
in murine models of intestinal inflammation (25, 37) and when 
transferred into GF are sufficient to induce experimental intesti-
nal inflammation (4, 37).
In the context of antibiotic-premedicated mice, we observed 
that re-colonization of the gastrointestinal tract with dysbiotic 
microbiota, but not with eubiotic microbiota, directly affected the 
activation status of iNKT cells (and of conventional CD4+ T cells), 
as demonstrated by their upregulation of CD69 and their skew 
toward a Th1/Th17 pro-inflammatory cytokine phenotype. At 
present, it remains to be elucidated whether iNKT cell activation 
depends on the recognition of stimulatory lipid antigens or rather 
on innate signals originated from bacterial pattern recognition 
molecules.
In this work, we observed that the functional imprinting of 
iNKT cells and of CD4+ T cells by a dysbiotic microbiota toward 
an activated/inflammatory Th1-Th17 cytokine profile after 
antibiotic treatment had important consequences when mice 
experienced subsequent intestinal inflammation. The transferred 
dysbiotic microbiota utilized to re-colonize mice showed a 
higher colitogenic potential than eubiotic microbiota in mice 
premedicated with antibiotics, and both iNKT  cells and CD4+ 
T cells manifested a sustained Th1/Th17 skewed cytokine profile 
in this experimental condition. Indeed, in line with previous 
reports (38), this observation suggests that antibiotic treatment 
might alter the colonization niche, favoring the selective engraft-
ment of pathogenic bacteria.
Induction of a pro-inflammatory phenotype by colonic 
T cells after antibiotic treatment by a dysbiotic microbiota might 
potentially have clinically relevant consequences. Patients that 
are genetically susceptible to harbor a dysbiotic microbiota, like 
those suffering from IBD, during the course of their disease might 
undergo treatments with antibiotics and experience episodes of 
intestinal inflammation. Indeed, current guidelines of ECCO (39, 
40) do not recommend antibiotic treatment for IBD patients, 
unless infective complications are suspected or ongoing and 
before surgical interventions.
As observed in our experimental model, upon cessation of 
antibiotic treatment, IBD patients could re-colonize their gas-
trointestinal tract with a dysbiosis-prone microbiota, capable to 
induce Th1/Th17 secreting colonic (iNK)T cells and bearing an 
activated phenotype. Thus, the synergistic action of antibiotics 
and the dysbiotic microbiota might potentially aggravate the 
outcomes of IBD-related inflammation.
Our experimental data suggest that, at least in the absence of 
genetically predisposing factors, a longer time between micro-
biota engraftment and DSS-induced intestinal inflammation 
is sufficient to reduce the colitogenic potential of the dysbiotic 
microbiota. If this effect is secondary to the filling of the coloniza-
tion niche by normal eubiotic bacteria remains to be elucidated. 
Nonetheless, it opens the possibility to evaluate therapeutic inter-
ventions, for example, by administering probiotics, to contrast 
the engraftment of pathobionts after antibiotic treatment.
sUMMarY anD cOnclUsiOn
In this study, we observed that antibiotic treatment profoundly 
altered the frequency of intestinal iNKT cells and the functions of 
both iNKT and CD4+ T cells even in the absence of concomitant 
intestinal inflammation. The presence of a dysbiotic microbiota 
after antibiotic treatment imprints colonic (iNK)T cells toward a 
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pro-inflammatory phenotype that contributes to aggravate intes-
tinal inflammation. Nonetheless, we observed that the inflamma-
tory potential of the dysbiotic microbiota decreased over time, 
at least in a system uncoupled with genetic predisposition to 
select and maintain the engraftment of pathobionts. At present, it 
remains to be elucidated whether (iNK)T cells activation in these 
conditions depends on the recognition of stimulatory lipidic 
or proteic antigens or rather on innate signals conveyed by the 
dysbiotic microbiota.
In immune-mediated intestinal pathologies, it has not been 
fully elucidated whether intestinal dysbiosis may be the cause 
or a consequence of intestinal inflammation. However, transfer 
of dysbiotic microflora or single commensal bacterial species in 
GF is sufficient to induce experimental intestinal inflammation 
and activate the mucosal immune system (4, 37). What it is now 
emerging is that antibiotic treatment can also induce dysbiosis 
and, as we observed, this can promote activating pro-inflamma-
tory immune cell responses in the colon.
Individuals with genetic predispositions to harbor a dysbiotic 
microbiota and to aberrantly activate the mucosal immune sys-
tem are, therefore, more exposed to unwanted pro-inflammatory 
immune responses after antibiotic treatment.
Albeit antibiotic treatment cannot be avoided, it should be 
kept in mind to predispose, especially for those individuals, 
treatments to re-equilibrate antibiotic-induced dysbiosis. For 
example, probiotics administration could contribute to contrast 
pathobionts engraftment and simultaneously switching-off 
mucosal immune cell activations.
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